Literature DB >> 7917932

Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

M Thörn1, F Pontén, R Bergström, P Sparén, H O Adami.   

Abstract

In Sweden, improvement in survival rates of patients with cutaneous malignant melanoma has counteracted the increase in incidence to produce a moderate rise in mortality. Our aim was to determine the possible impact of drift in diagnostic criteria, earlier diagnosis and changing biological features of the tumours upon trends in survival. We studied a stratified sample of 528 patients diagnosed between 1960 and 1984 in a strictly defined geographical region. No evidence of drift in diagnostic criteria was found. The proportion of patients with invasion level Clark II increased from 3.2% in 1960-64 to 22.5% in 1980-84, the proportion of thin melanomas (< or = 0.75 mm) increased from 9.4% to 31.5% and the tumour thickness decreased significantly between each 5 year period of diagnosis. These changes are most likely the results of earlier diagnosis. However, changes in tumour characteristics have occurred, since the proportion of superficially spreading malignant melanoma increased from 35% in 1960-64 to 51% in 1980-84 and the proportion of acral lentiginous melanoma decreased from 11% to 2%. The proportion of nodular melanomas remained fairly constant. The proportion of tumours with lymphocytic reaction did not change, whereas those with histological regression increased slightly. Proportional hazards analyses showed a significantly lower survival in patients diagnosed in 1960-64 but no apparent trend after 1965. This finding remained after adjustment for all studied clinical and histopathological factors which point towards changes in unmeasured biological features of the disease.

Entities:  

Mesh:

Year:  1994        PMID: 7917932      PMCID: PMC2033418          DOI: 10.1038/bjc.1994.388

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.

Authors:  M Thörn; R Bergström; H O Adami; U Ringborg
Journal:  Am J Epidemiol       Date:  1990-12       Impact factor: 4.897

2.  Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions?

Authors:  R Philipp; A Hastings; J Briggs; J Sizer
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

3.  Trends in incidence of malignant melanoma of the skin in Denmark 1943-1982.

Authors:  A Osterlind; O Møller Jensen
Journal:  Recent Results Cancer Res       Date:  1986

4.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

5.  The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry.

Authors:  M Thörn; H O Adami; U Ringborg; R Bergström; U Krusemo
Journal:  Eur J Cancer Clin Oncol       Date:  1989-03

6.  Trends in survival from malignant melanoma: remarkable improvement in 23 years.

Authors:  M Thörn; H O Adami; R Bergström; U Ringborg; U B Krusemo
Journal:  J Natl Cancer Inst       Date:  1989-04-19       Impact factor: 13.506

7.  Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982.

Authors:  K T Drzewiecki; H Frydman; K Andersen; H Poulsen; C Ladefoged; P Vibe
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

8.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

Authors:  R MacKie; J A Hunter; T C Aitchison; D Hole; K Mclaren; R Rankin; K Blessing; A T Evans; A W Hutcheon; D H Jones
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

9.  The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors.

Authors:  A Osterlind; M A Tucker; K Hou-Jensen; B J Stone; G Engholm; O M Jensen
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

10.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely.

Authors:  E P van der Esch; C S Muir; J Nectoux; G Macfarlane; P Maisonneuve; H Bharucha; J Briggs; R A Cooke; A G Dempster; W B Essex
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

View more
  2 in total

1.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

2.  Cutaneous malignant melanoma in Northern Ireland.

Authors:  P J Pedlow; M Y Walsh; C C Patterson; R J Atkinson; W S Lowry
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.